Page 36 - Sanket Koul

Cardiac stents to cost 2% more as regulator allows prices to be raised

National Pharmaceutical Pricing Authority allows manufacturers to make adjustment for inflation

Parl panel flags concerns over CBSE's dual board exam plan for Class 10

In its draft policy released last month, the CBSE had proposed conducting Class 10 board exams twice in an academic year from 2026

NPPA revises ceiling prices for over 900 drug formulations from April 1

With the changes, manufacturers will be allowed to increase the maximum retail price (MRP) of scheduled formulations on the basis of WPI without needing any prior approval from the government

Centre asks states to activate heat action plans, boost preparedness

The weatherman has also warned of "double heatwave" days in northwest India this summer season

Proposed circle rate hike to make property costlier in Noida, Jewar

Experts believe potential rise may enhance investor confidence in long run

NPPA to allow 1.74% hike in MRP of scheduled drugs in line with WPI rise

With this, manufacturers will be allowed to increase the maximum retail price (MRP) of scheduled formulations on the basis of WPI without needing any prior approval from the government in this regard

India may soon train select countries on best drug regulatory practices

The project will be an extension of the CDSCO and NIHFW's ongoing training programmes with drug inspectors from the central and state drug authorities

CDSCO asks MSME pharma firms to apply online for Schedule M extension

This comes after the health ministry had on February 11 formally extended the deadline for implementing the revised Schedule M by one year for pharma companies with an annual turnover below Rs 250 cr

Centre to expand its TB elimination campaign all over India: JP Nadda

This comes after the government's 100-day intensified TB screening campaign concluded on March 24, which is also World TB Day

DCDC Kidney Care receives Rs 150 crore investment from ABC Impact

The company currently operates more than 200 centres across India, both under public-private partnerships (PPP) and company-owned standalone clinics, serving over 20,000 patients annually

Real estate major DLF eyes Rs 74k cr in sales from new housing projects

Realty major targeting luxury housing market with products totalling 26 million square feet in pipeline

Housing supply down 34%, sales drop 23% in top 9 cities in Q1CY25: Report

Supply drops below 100,000 units for the third straight quarter

Mumbai temperatures hit five-year high; heat-related ailments rise 10-20%

Delhi, Kolkata expect surge in heat-related emergencies

Booster shot: Mounjaro may emerge as a sweet pill for Eli Lilly in India

Analysts say the diabetes and obesity drug can be a Rs 500 crore opportunity for the firm

Signature Global acquires 8.39 acre land in Gurugram for Rs 282 crore

The company said that the overall developable potential of the acquired land would be approximately 2 million square feet, with a total revenue of around Rs 3,200 crore

Trump Organisation to foray into Indian commercial real estate sector

"Estimated to be finished by 2029, the 1.6 million square feet centre is expected to generate sales exceeding Rs 2,500 crore," Kalpesh Mehta, founder of Tribeca developers told Business Standard

Medical device body asks Centre to revisit import duty reduction talks

This comes just days after economic think tank GTRI had asked government officials to seek reciprocity and improve market access for the Indian medical devices sector

Capital appreciation steals a march on rental growth in key markets

NCR, MMR, Hyderabad see higher capital appreciation between 2021 and 2024, says Anarock report

Parliamentary committee flags underuse of health infra mission funds

The parliamentary panel, chaired by Samajwadi Party (SP) member Ram Gopal Yadav, expressed concerns over the scheme's absorption capacity and the professional efficiency of its implementing agency

Licensing delays pushing medical device makers abroad: Parliament panel

Implementation of tracking system, independent advisory board, lateral entry among panel's recommendations to remove CDSCO's perception of licence raj